Skip to Main content Skip to Navigation
Journal articles

Hepatitis C virus prevention and care for drug injectors: the French approach

J-M Delile Victor de Ledinghen 1 Marie Jauffret-Roustide 2 P Roux 3 B Reiller J Foucher 1 D Dhumeaux
1 Hôpital Haut-Lévêque [CHU Bordeaux]
2 CERMES3 - UMR 8211 / U988 / UM 7 - CERMES3 - Centre de recherche Médecine, sciences, santé, santé mentale, société
3 SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD - Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale
Abstract : After France removed hepatitis C treatment reimbursement restrictions on 25 May 2016, an expert report presented recommendations, which focused on vulnerable groups including people who inject drugs (PWID). This commentary presents the key points of the chapter with a particular focus on policy.
Document type :
Journal articles
Complete list of metadata
https://hal-cnrs.archives-ouvertes.fr/hal-03480530
Contributor : Colette Orange Connect in order to contact the contributor
Submitted on : Tuesday, December 14, 2021 - 5:09:36 PM
Last modification on : Saturday, January 8, 2022 - 3:15:45 AM

Links full text

openaccess

Identifiers

Collections

CNRS | EHESS | UNIV-PARIS5 | UNIV-PARIS | UP-SOCIETES-HUMANITES | CERMES3 | USPC | UNIV-AMU | U1252

Citation

J-M Delile, Victor de Ledinghen, Marie Jauffret-Roustide, P Roux, B Reiller, et al.. Hepatitis C virus prevention and care for drug injectors: the French approach. Hepatology, medicine and policy, Biomed central, 2018, 3 (1), pp.7. ⟨10.1186/s41124-018-0033-8⟩. ⟨hal-03480530⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Les métriques sont temporairement indisponibles